Anticancer potential of diarylidenyl piperidone derivatives, HO-4200 and H-4318, in cisplatin resistant primary ovarian cancer

Volume 17, Issue 10, October 2016, Page 1107-1115
.


from Cancer via ola Kala on Inoreader http://ift.tt/2dqdgIV
via IFTTT